Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis

Clinical Immunology

Volumn 150, Issue 2, 2014, Pages 220-224

  Janssen, Erin ^a   Tsitsikov, Erdyni ^a   Al Herz, Waleed ^b   Lefranc, Gerard ^c   Megarbane, Andre ^d   Dasouki, Majed ^e   Bonilla, Francisco A ^a   Chatila, Talal ^a   Schneider, Lynda ^a   Geha, Raif S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b KUWAIT UNIVERSITY   (Kuwait)

^c INSTITUTE OF HUMAN GENETICS   (France)

^d SAINT JOSEPH UNIVERSITY   (Lebanon)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; B cell; DOCK8; Hyper IgE; T cell

Indexed keywords

BIOLOGICAL MARKER; DEDICATOR OF CYTOKINESIS 8; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL IMMUNOLOGY; CONTROLLED STUDY; DEDICATOR OF CYTOKINESIS 8 DEFICIENCY; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MEMORY CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ATOPIC DERMATITIS;; B CELL; DOCK8;; HYPER-IGE;; T CELL;;

BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; EXONS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MUTATION; ODDS RATIO; PHENOTYPE;

EID: 84892474895     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.12.006     Document Type: Article

References (24)

1. Zhang Q., Davis J.C., Dove C.G., Su H.C. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis. Markers 2010, 29:131-139.
2. Sanal O., Jing H., Ozgur T., Ayvaz D., Strauss-Albee D.M., Ersoy-Evans S., Tezcan I., Turkkani G., Matthews H.F., Haliloglu G., Yuce A., Yalcin B., Gokoz O., Oguz K.K., Su H.C. Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J. Clin. Immunol. 2012, 32:698-708.
3. Su H.C. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr. Opin. Allergy Clin. Immunol. 2010, 10:515-520.
4. McDonald D.R., Massaad M.J., Johnston A., Keles S., Chatila T., Geha R.S., Pai S.Y. Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J. Allergy Clin. Immunol. 2010, 126. (1304-5 e3).
5. Ghosh S., Schuster F.R., Fuchs I., Laws H.J., Borkhardt A., Meisel R. Treosulfan-based conditioning in DOCK8 deficiency: complete lympho-hematopoietic reconstitution with minimal toxicity. Clin. Immunol. 2012, 145:259-261.
6. Boztug H., Karitnig-Weiss C., Ausserer B., Renner E.D., Albert M.H., Sawalle-Belohradsky J., Belohradsky B.H., Mann G., Horcher E., Rummele-Waibel A., Geyeregger R., Lakatos K., Peters C., Lawitschka A., Matthes-Martin S. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr. Hematol. Oncol. 2012, 29:585-594.
7. Metin A., Tavil B., Azik F., Azkur D., Ok-Bozkaya I., Kocabas C., Tunc B., Uckan D. Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatr. Transplant. 2012, 16:398-399.
8. Barlogis V., Galambrun C., Chambost H., Lamoureux-Toth S., Petit P., Stephan J.L., Michel G., Fischer A., Picard C. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J. Allergy Clin. Immunol. 2011, 128. (420-22 e2).
9. Bittner T.C., Pannicke U., Renner E.D., Notheis G., Hoffmann F., Belohradsky B.H., Wintergerst U., Hauser M., Klein B., Schwarz K., Schmid I., Albert M.H. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin. Padiatr. 2010, 222:351-355.
10. Gatz S.A., Benninghoff U., Schutz C., Schulz A., Honig M., Pannicke U., Holzmann K.H., Schwarz K., Friedrich W. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2011, 46:552-556.
11. Engelhardt K.R., McGhee S., Winkler S., Sassi A., Woellner C., Lopez-Herrera G., Chen A., Kim H.S., Lloret M.G., Schulze I., Ehl S., Thiel J., Pfeifer D., Veelken H., Niehues T., Siepermann K., Weinspach S., Reisli I., Keles S., Genel F., Kutukculer N., Camcioglu Y., Somer A., Karakoc-Aydiner E., Barlan I., Gennery A., Metin A., Degerliyurt A., Pietrogrande M.C., Yeganeh M., Baz Z., Al-Tamemi S., Klein C., Puck J.M., Holland S.M., McCabe E.R., Grimbacher B., Chatila T.A. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 2009, 124. (1289-302 e4).
12. Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., Matthews H.F., Davis J., Turner M.L., Uzel G., Holland S.M., Su H.C. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 2009, 361:2046-2055.
13. Alsum Z., Hawwari A., Alsmadi O., Al-Hissi S., Borrero E., Abu-Staiteh A., Khalak H.G., Wakil S., Eldali A.M., Arnaout R., Al-Ghonaium A., Al-Muhsen S., Al-Dhekri H., Al-Saud B., Al-Mousa H. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J. Clin. Immunol. 2013, 33:55-67.
14. Jabara H.H., McDonald D.R., Janssen E., Massaad M.J., Ramesh N., Borzutzky A., Rauter I., Benson H., Schneider L., Baxi S., Recher M., Notarangelo L.D., Wakim R., Dbaibo G., Dasouki M., Al-Herz W., Barlan I., Baris S., Kutukculer N., Ochs H.D., Plebani A., Kanariou M., Lefranc G., Reisli I., Fitzgerald K.A., Golenbock D., Manis J., Keles S., Ceja R., Chatila T.A., Geha R.S. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat. Immunol. 2012, 13:612-620.
15. Silverberg J.I., Simpson E.L. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr. Allergy Immunol. 2013, 24:476-486.
16. Rajka G., Langeland T. Grading of the severity of atopic dermatitis. Acta Derm. Venereol. Suppl. (Stockh) 1989, 144:13-14.
17. Piatosa B., Wolska-Kusnierz B., Pac M., Siewiera K., Galkowska E., Bernatowska E. B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood. Cytometry B Clin. Cytom. 2010, 78:372-381.
18. Shearer W.T., Rosenblatt H.M., Gelman R.S., Oyomopito R., Plaeger S., Stiehm E.R., Wara D.W., Douglas S.D., Luzuriaga K., McFarland E.J., Yogev R., Rathore M.H., Levy W., Graham B.L., Spector S.A. Lymphocyte subsets in healthy children from birth through 18years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J. Allergy Clin. Immunol. 2003, 112:973-980.
19. Randall K.L., Lambe T., Johnson A.L., Treanor B., Kucharska E., Domaschenz H., Whittle B., Tze L.E., Enders A., Crockford T.L., Bouriez-Jones T., Alston D., Cyster J.G., Lenardo M.J., Mackay F., Deenick E.K., Tangye S.G., Chan T.D., Camidge T., Brink R., Vinuesa C.G., Batista F.D., Cornall R.J., Goodnow C.C. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat. Immunol. 2009, 10:1283-1291.
20. Randall K.L., Chan S.S., Ma C.S., Fung I., Mei Y., Yabas M., Tan A., Arkwright P.D., Al Suwairi W., Lugo Reyes S.O., Yamazaki-Nakashimada M.A., Garcia-Cruz Mde L., Smart J.M., Picard C., Okada S., Jouanguy E., Casanova J.L., Lambe T., Cornall R.J., Russell S., Oliaro J., Tangye S.G., Bertram E.M., Goodnow C.C. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J. Exp. Med. 2011, 208:2305-2320.
21. Lambe T., Crawford G., Johnson A.L., Crockford T.L., Bouriez-Jones T., Smyth A.M., Pham T.H., Zhang Q., Freeman A.F., Cyster J.G., Su H.C., Cornall R.J. DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur. J. Immunol. 2011, 41:3423-3435.
22. aan de Kerk D.J., van Leeuwen E.M., van Leeuwen E.M., Jansen M.H., van den Berg J.M., Alders M., Vermont C.L., van Lier R.A., Pals S.T., Kuijpers T.W. Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis. Clin. Immunol. 2013, 149:25-31.
23. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annu. Rev. Immunol. 2009, 27:267-285.
24. Zouali M., Richard Y. Marginal zone B-cells, a gatekeeper of innate immunity. Front. Immunol. 2011, 2:63.